메뉴 건너뛰기




Volumn 55, Issue 1, 2016, Pages 59-67

Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial

Author keywords

[No Author keywords available]

Indexed keywords

ETIDRONIC ACID TC 99M; SODIUM FLUORIDE F 18; BISPHOSPHONIC ACID DERIVATIVE; FLUORODEOXYGLUCOSE F 18; HYDROXYMETHANEDIPHOSPHONIC ACID; TECHNETIUM DERIVATIVE;

EID: 84951840268     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2015.1027411     Document Type: Article
Times cited : (172)

References (25)
  • 2
    • 4644261592 scopus 로고    scopus 로고
    • Mechanisms of bone metastasis
    • Roodman GD. Mechanisms of bone metastasis. N Engl J Med 2004; 350: 1655-64.
    • (2004) N Engl J Med , vol.350 , pp. 1655-1655
    • Roodman, G.D.1
  • 3
  • 5
    • 0036784264 scopus 로고    scopus 로고
    • Prognostic value of bone scan in patients with metastatic prostate cancer treated initially with androgen deprivation therapy
    • Rigaud J, Tiguert R, Le NL, Karam G, Glemain P, Buzelin JM, et al. Prognostic value of bone scan in patients with metastatic prostate cancer treated initially with androgen deprivation therapy. J Urol 2002; 168: 1423-6.
    • (2002) J Urol , vol.168 , pp. 1423-1423
    • Rigaud, J.1    Tiguert, R.2    Le, N.L.3    Karam, G.4    Glemain, P.5    Buzelin, J.M.6
  • 6
    • 33746187320 scopus 로고    scopus 로고
    • The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single-and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT
    • Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single-and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med 2006; 47: 287-97.
    • (2006) J Nucl Med , vol.47 , pp. 287-287
    • Even-Sapir, E.1    Metser, U.2    Mishani, E.3    Lievshitz, G.4    Lerman, H.5    Leibovitch, I.6
  • 7
    • 34548245099 scopus 로고    scopus 로고
    • Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: Diagnostic and cost-effectiveness and comparison with current detection strategies
    • Lecouvet FE, Geukens D, Stainier A, Jamar F, Jamart J, dOthee BJ, et al. Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: Diagnostic and cost-effectiveness and comparison with current detection strategies. J Clin Oncol 2007; 25: 3281-7.
    • (2007) J Clin Oncol , vol.25 , pp. 3281-3281
    • Lecouvet, F.E.1    Geukens, D.2    Stainier, A.3    Jamar, F.4    Jamart, J.5    D'Othee, B.J.6
  • 8
    • 0035668311 scopus 로고    scopus 로고
    • Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer
    • Schirrmeister H, Glatting G, Hetzel J, Nussle K, Arslandemir C, Buck AK, et al. Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med 2001; 42: 1800-4.
    • (2001) J Nucl Med , vol.42 , pp. 1800-1800
    • Schirrmeister, H.1    Glatting, G.2    Hetzel, J.3    Nussle, K.4    Arslandemir, C.5    Buck, A.K.6
  • 9
    • 1542609199 scopus 로고    scopus 로고
    • Assessment of malignant skeletal disease: Initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT
    • Even-Sapir E, Metser U, Flusser G, Zuriel L, Kollender Y, Lerman H, et al. Assessment of malignant skeletal disease: Initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med 2004; 45: 272-8.
    • (2004) J Nucl Med , vol.45 , pp. 272-272
    • Even-Sapir, E.1    Metser, U.2    Flusser, G.3    Zuriel, L.4    Kollender, Y.5    Lerman, H.6
  • 10
    • 25444470494 scopus 로고    scopus 로고
    • Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities1
    • Even-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities1. J Nucl Med 2005; 46: 1356-67.
    • (2005) J Nucl Med , vol.46 , pp. 1356-1356
    • Even-Sapir, E.1
  • 11
    • 84861479889 scopus 로고    scopus 로고
    • Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases
    • Iagaru A, Mittra E, Dick DW, Gambhir SS. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases. Mol Imaging Biol 2012; 14: 252-9.
    • (2012) Mol Imaging Biol , vol.14 , pp. 252-252
    • Iagaru, A.1    Mittra, E.2    Dick, D.W.3    Gambhir, S.S.4
  • 12
    • 0034082819 scopus 로고    scopus 로고
    • Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: Preliminary clinical experience
    • Walker R, Kessar P, Blanchard R, Dimasi M, Harper K, DeCarvalho V, et al. Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: Preliminary clinical experience. J Magn Reson Imaging 2000; 11: 343-50.
    • (2000) J Magn Reson Imaging , vol.11 , pp. 343-343
    • Walker, R.1    Kessar, P.2    Blanchard, R.3    Dimasi, M.4    Harper, K.5    DeCarvalho, V.6
  • 16
    • 77649335960 scopus 로고    scopus 로고
    • Detection of bone metastases using diffusion weighted magnetic resonance imaging: Comparison with (11)C-methionine PET and bone scintigraphy
    • Goudarzi B, Kishimoto R, Komatsu S, Ishikawa H, Yoshikawa K, Kandatsu S, et al. Detection of bone metastases using diffusion weighted magnetic resonance imaging: Comparison with (11)C-methionine PET and bone scintigraphy. Magn Reson Imaging 2010; 28: 372-9.
    • (2010) Magn Reson Imaging , vol.28 , pp. 372-372
    • Goudarzi, B.1    Kishimoto, R.2    Komatsu, S.3    Ishikawa, H.4    Yoshikawa, K.5    Kandatsu, S.6
  • 17
    • 20444415268 scopus 로고    scopus 로고
    • Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone
    • Ghanem N, Uhl M, Brink I, Schafer O, Kelly T, Moser E, et al. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol 2005; 55: 41-55.
    • (2005) Eur J Radiol , vol.55 , pp. 41-41
    • Ghanem, N.1    Uhl, M.2    Brink, I.3    Schafer, O.4    Kelly, T.5    Moser, E.6
  • 18
    • 34248674372 scopus 로고    scopus 로고
    • Screening for bone metastases: Whole-body MRI using a 32-channel system versus dual-modality PET-CT
    • Schmidt GP, Schoenberg SO, Schmid R, Stahl R, Tiling R, Becker CR, et al. Screening for bone metastases: Whole-body MRI using a 32-channel system versus dual-modality PET-CT. Eur Radiol 2007; 17: 939-49.
    • (2007) Eur Radiol , vol.17 , pp. 939-939
    • Schmidt, G.P.1    Schoenberg, S.O.2    Schmid, R.3    Stahl, R.4    Tiling, R.5    Becker, C.R.6
  • 19
    • 84861608873 scopus 로고    scopus 로고
    • Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
    • Lecouvet FE, El MJ, Collette L, Coche E, Danse E, Jamar F, et al. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol 2012; 62: 68-75.
    • (2012) Eur Urol , vol.62 , pp. 68-68
    • Lecouvet, F.E.1    El, M.J.2    Collette, L.3    Coche, E.4    Danse, E.5    Jamar, F.6
  • 20
    • 38549121895 scopus 로고    scopus 로고
    • McNemar chi2 test revisited: Comparing sensitivity and specificity of diagnostic examinations
    • Trajman A, Luiz RR. McNemar chi2 test revisited: Comparing sensitivity and specificity of diagnostic examinations. Scand J Clin Lab Invest 2008; 68: 77-80.
    • (2008) Scand J Clin Lab Invest , vol.68 , pp. 77-77
    • Trajman, A.1    Luiz, R.R.2
  • 21
    • 0034090049 scopus 로고    scopus 로고
    • Bootstrap estimation of diagnostic accuracy with patient-clustered data
    • Rutter CM. Bootstrap estimation of diagnostic accuracy with patient-clustered data. Acad Radiol 2000; 7: 413-9.
    • (2000) Acad Radiol , vol.7 , pp. 413-413
    • Rutter, C.M.1
  • 22
    • 0020524559 scopus 로고
    • A method of comparing the areas under receiver operating characteristic curves derived from the same cases
    • Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-43.
    • (1983) Radiology , vol.148 , pp. 839-839
    • Hanley, J.A.1    McNeil, B.J.2
  • 24
    • 70249098856 scopus 로고    scopus 로고
    • Diffusion-weighted MR imaging: Adjunct or alternative to T1-weighted MR imaging for prostate carcinoma bone metastases?
    • Lecouvet FE, Vande Berg BC, Malghem J, Omoumi P, Simoni P. Diffusion-weighted MR imaging: Adjunct or alternative to T1-weighted MR imaging for prostate carcinoma bone metastases? Radiology 2009; 252: 624.
    • (2009) Radiology , vol.252 , pp. 624
    • Lecouvet, F.E.1    Vande Berg, B.C.2    Malghem, J.3    Omoumi, P.4    Simoni, P.5
  • 25
    • 68249139022 scopus 로고    scopus 로고
    • Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer
    • Venkitaraman R, Cook GJ, Dearnaley DP, Parker CC, Khoo V, Eeles R, et al. Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer. J Med Imaging Radiat Oncol 2009; 53: 241-7.
    • (2009) J Med Imaging Radiat Oncol , vol.53 , pp. 241-241
    • Venkitaraman, R.1    Cook, G.J.2    Dearnaley, D.P.3    Parker, C.C.4    Khoo, V.5    Eeles, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.